Table 1: Characteristics of patients with CF and controls.
| Controls | CF total | CF no CFRD | CF CFRD | |
| Number (n) | 23 | 39 | 25 | 14 |
| Men/Women (n) | 11/12 | 18/21 | 13/12 | 5/9 |
| Age (y) | 31 (23; 35) | 24 (21; 35) | 23 (21; 34)* | 26 (23; 38) |
| CFTR genotype° | 0/0/0/23 | 19/14/6/0x | 12/8/5/0 | 7/6/1/0 |
| BMI (kg/m2) | 22.0 (20.7; 24.8) | 18.0 (16.8; 19.7)**** | 18.4 (17.2; 19.8)**** | 17.8 (15.5; 19.8)**** |
| FEV1 (%) | not analyzed | 28 (21; 38) | 32 (26; 46) | 23 (19; 31) |
| A1c (%)1 | 5.4 (5.3; 5.6) | 6.1 (5.9; 6.3)**** | 6.0 (5.8; 6.2)**** | 6.2 (6.0; 6.6)**** |
| A1c (mmol/mol)1 | 36 (34; 38) | 43 (41; 45)**** | 42 (40; 44)**** | 44 (42; 49)**** |
| Glu0' (mmol/l) | 4.5 (4.2; 4.7) | 4.7 (4.5; 5.3)* | 4.6 (4.5; 5.1) | 5.2 (4.6; 5.9)** |
| Albumin (g/l)2 | 41 (39; 45) | 38 (35; 41)** | 38 (35; 41)* | 38 (35; 40)** |
| CRP (mg/l)3 | 0 (0; 2) | 11 (5; 30)**** | 12 (5; 38)**** | 7 (4; 22)*** |
Data are expressed as median (IQR).
°Phe508del homozygous/heterozygous/other genotype/not analysed.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 for the comparison controls vs. CF total/CF no CFRD/CF CFRD.
1: Measured in 13 of 23 controls; 2: Measured in 19 of 23 controls and 38 of 39 CF patients; 3: Measured in 21 of 23 controls.